Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

786382

	registered interest
	date	07/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Practitioners: Attendance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the funding per patient is awarded to Babylon Health as part of its GP appointment trial.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	112146
	answer	answer is ministerial correction date of answer 17/11/2017 answer text <p>“GP at Hand” is a practice operating under the traditional general medical services (GMS) contract. The normal weighted capitation allowances practices receive through a GMS contract remain the same.</p><p> </p><p>Any arrangement the practice have agreed with Babylon Health is commercially sensitive information that remains with the practice.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/11/2017 11:50:30 answering member 4067 label Biography information for Steve Brine
	tabling member	4418 label Biography information for Justin Madders

927822

	registered interest
	date	20/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Costs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the cost to the public purse was of NHS treatment for people with (a) smoking-related, (b) alcohol-related and (c) obesity-related illnesses in the most recent year for which data are available.
	tabling member constituency	Tewkesbury
	tabling member printed	Mr Laurence Robertson
	uin	155666
	answer	answer is ministerial correction date of answer 28/06/2018 answer text <p>‘Towards a smokefree generation: A Tobacco Control Plan for England 2017-2022’, published in July 2017, suggests that in 2014/15, smoking cost the National Health Service in England £2.5 billion. The figure quoted includes the cost of treating smokers in primary and secondary care, general practitioner visits, nurse visits, prescriptions, outpatient visits and hospital admissions.</p><p> </p><p>Data on NHS spending on treatment of alcohol related conditions is not collected centrally. However, the costs to the NHS in England associated with alcohol misuse are estimated at £3.5 billion each year.</p><p> </p><p>‘The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006-07 NHS costs’ estimated that overweight and obesity cost the NHS in the United Kingdom £5.1 billion per year. This figure was uplifted to £6.1 billion in 2014/15 to take account of inflation.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/06/2018 11:18:59 answering member 4067 label Biography information for Steve Brine
	tabling member	253 label Biography information for Mr Laurence Robertson

1064905

	registered interest
	date	22/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Tuberculosis: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the adequacy of (a) treatment and (b) support for people with with tuberculosis.
	tabling member constituency	Stirling
	tabling member printed	Stephen Kerr
	uin	224822
	answer	answer is ministerial correction date of answer 04/03/2019 answer text <p>‘The Collaborative Tuberculosis (TB) Strategy for England 2015 to 2020’ was developed by Public Health England (PHE) in partnership with NHS England and aims to reduce suffering and harm caused by TB through lowering the incidence of the disease in England. The Strategy is available at the following link:</p><p> </p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/403231/Collaborative_TB_Strategy_for_England_2015_2020_.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/403231/Collaborative_TB_Strategy_for_England_2015_2020_.pdf</a></p><p> </p><p>The strategy aims to tackle TB in under-served populations through the commissioning of integrated, multidisciplinary, case management and support for under-served groups. This multidisciplinary support, which may include third sector organisations, should provide targeted outreach interventions, informed by proven models such as ‘Find and Treat’ in London, including specific services for active case finding among homeless people and those attending substance misuse services.</p><p> </p><p>In January 2016, the National Institute for Health and Care Excellence published a clinical guideline that covers preventing, identifying and managing latent and active TB in children, young people and adults. This is available at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/ng33" target="_blank">https://www.nice.org.uk/guidance/ng33</a></p><p> </p><p>In 2017, PHE and the National Health Service issued a ‘TB Service Specification and Clinical Policy’ for use by commissioners and TB services. This builds on the work of the strategy to:</p><p>- improve rapid diagnosis and treatment of active TB disease;</p><p>- prevention of TB by treating latent infections; and</p><p>- focus on complex cases with antimicrobial resistance and patients with other risk factors for poor treatment outcome, such as homelessness.</p><p> </p><p>NHS England is supporting those clinical commissioning groups (CCGs) with the highest burden of disease to provide latent TB testing and treatment programmes which are essential for reducing the incidence of active TB. In 2018/19, the 46 CCGs with the highest burden of disease were supported with £3,594,000 to provide this service.</p><p> </p><p>According to the latest annual report ‘Tuberculosis in England: 2018’ published by PHE, since the peak of TB incidence in England in 2011 the number of people notified with TB had fallen by nearly 40% in 2017. The incidence rate in 2017 was 9.2 per 100,000 population, the lowest recorded rate for England, which for the first time falls under the 10 per 100,000 World Health Organization definition of a low incidence country. The report is available at the following link:</p><p><strong> </strong></p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/774091/TB_Annual_Report_2018_2.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/774091/TB_Annual_Report_2018_2.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 04/03/2019 17:06:37 answering member 4067 label Biography information for Steve Brine
	tabling member	4604 label Biography information for Stephen Kerr

1061221

	registered interest
	date	14/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Antibiotics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage the NHS to preferentially purchase antibiotics manufactured in environmentally sustainable ways, as set out in the new Antimicrobial Resistance Strategy, published on 24 January 2019.
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	uin	221729
	answer	answer is ministerial correction date of answer 22/02/2019 answer text <p>‘Tackling antimicrobial resistance 2019–2024: The UK’s five-year national action plan’ sets out a commitment to minimise antimicrobial contamination. The United Kingdom will work with other countries to ensure responsible antimicrobial procurement from manufacturers with transparent world class environmental stewardship in their supply chains.</p><p>Following the publication of the national action plan, NHS England’s Commercial Medicines Unit is considering the ways in which future framework agreements could be modified to address relevant aspects, including environmental sustainability.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/02/2019 08:12:03 answering member 4067 label Biography information for Steve Brine
	tabling member	4382 label Biography information for Daniel Zeichner

1077132

	registered interest
	date	25/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to his policy paper Tackling antimicrobial resistance 2019 to 2024: the UK's 5-year national action plan, whether he has made an assessment of the effect of the UK’s childhood vaccination programme on levels of anti-microbial resistance in the UK; and if he will make a statement.
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	uin	225531
	answer	answer is ministerial correction date of answer 05/03/2019 answer text <p>‘Tackling antimicrobial resistance (2019-24): The UK’s five-year national action plan’, recognises that immunisation is one of the most effective public health interventions to prevent infection in humans and animals.</p><p> </p><p>Vaccination programmes have been successful and cost-effective in helping avert millions of cases of childhood illness, with large reductions in cases of serious infections. By reducing the burden of infection, vaccine programmes play an important role in reducing levels of antibiotic prescribing and therefore the selective pressure for the emergence and spread of antibiotic resistance.</p><p> </p><p>The childhood pneumococcal vaccine programme has led to declines in some antibiotic resistant clones of pneumococcus that are covered by the PCV13 vaccine. Also, the influenza vaccination programme helps to reduce the use of and requirement for antibiotics by reducing cases of respiratory illness and of secondary bacterial pneumonia.</p><p> </p><p>In addition, the new Joint Committee on Vaccination and Immunisation (JCVI) Healthcare Associated Infections Working Group, set up to review and provide preliminary advice to JCVI on the potential use of appropriate vaccines in the United Kingdom, will help to address this issue.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/03/2019 17:19:23 answering member 4067 label Biography information for Steve Brine
	tabling member	4382 label Biography information for Daniel Zeichner

1052243

	registered interest
	date	31/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to establish an evidential basis on the time taken to diagnose disease in the NHS as part of the Antimicrobial Resistance Strategy.
	tabling member constituency	Bristol West
	tabling member printed	Thangam Debbonaire
	uin	215246
	answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>‘Tackling Antimicrobial Resistance (2019-2024): the UK’s five-year national action plan’ recognises that stewardship programmes are needed for both therapeutics and diagnostics. Good diagnostic stewardship promotes appropriate and timely testing.</p><p> </p><p>Evidence suggests that a third of prescriptions in primary care do not have an associated diagnosis recorded. The national action plan sets out an ambition to improve the evidence base about diagnoses and prescriptions by linking and analysing clinical data sets.</p><p> </p><p>Through the joint sepsis/Antimicrobial Resistance Commissioning for Quality Innovation data we know that the number of patients being identified with a suspicion of sepsis or severe infection has increased and that a majority of those patients have their treatment reviewed within 24-72 hours, following the confirmation of diagnostic test results.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:40:27 answering member 4067 label Biography information for Steve Brine
	tabling member	4433 label Biography information for Thangam Debbonaire

1052242

	registered interest
	date	31/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has plans to increase the level of investment and funding for training and employing NHS microbiologists on long term contracts to increase diagnostic capacity as part of the government strategy to tackle antimicrobial resistance.
	tabling member constituency	Bristol West
	tabling member printed	Thangam Debbonaire
	uin	215245
	answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>‘Tackling Antimicrobial Resistance (2019-2024): the UK’s five-year national action plan’ includes the commitment to assess current and future workforce needs to ensure capability and capacity for strong infection prevention and control and antimicrobial stewardship. The assessment will cover a range of roles, including microbiology. The results of the assessment will be used to develop further workforce targets.</p><p> </p><p>The NHS England Long Term Plan makes the commitment to implement the human health aspects of the national action plan.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:29:36 answering member 4067 label Biography information for Steve Brine
	tabling member	4433 label Biography information for Thangam Debbonaire

1006074

	registered interest
	date	13/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 October 2018 to Question 180245 on Prescription Drugs, for what reason his Department did not include individual testimony; and what proportion of the published evidence was submitted by pharmaceutical companies.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	190913
	answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>‘Prescribed Medicines: An Evidence Review’ is a public health evidence review of the published evidence and available data. This process is distinct from a public inquiry so the inclusion of individual testimonies would not be appropriate.</p><p> </p><p>Public Health England (PHE) is aware of the importance and relevance of the experience of patients in understanding the issues. The review will give significant prominence to the patients’ experiences and examine existing service models through published research and other methods, for example analysis of annual reports of various withdrawal charities.</p><p> </p><p>The call for evidence was open to all parties, including pharmaceutical companies. The call for evidence has now closed. The National Guideline Centre (NGC) will provide details on the evidence submitted in their rapid evidence assessment report. The report is due in early 2019.</p><p> </p><p>A non-disclosure agreement was not made between PHE and the NGC in relation to the review of literature on prescribed medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 190914 question first answered 20/11/2018 15:07:46 answering member 4067 label Biography information for Steve Brine
	tabling member	4436 label Biography information for Cat Smith

1006075

	registered interest
	date	13/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether a non-disclosure agreement was made between Public Health England and the National Guideline Centre in relation to the review of literature on prescribed medicines.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	190914
	answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>‘Prescribed Medicines: An Evidence Review’ is a public health evidence review of the published evidence and available data. This process is distinct from a public inquiry so the inclusion of individual testimonies would not be appropriate.</p><p> </p><p>Public Health England (PHE) is aware of the importance and relevance of the experience of patients in understanding the issues. The review will give significant prominence to the patients’ experiences and examine existing service models through published research and other methods, for example analysis of annual reports of various withdrawal charities.</p><p> </p><p>The call for evidence was open to all parties, including pharmaceutical companies. The call for evidence has now closed. The National Guideline Centre (NGC) will provide details on the evidence submitted in their rapid evidence assessment report. The report is due in early 2019.</p><p> </p><p>A non-disclosure agreement was not made between PHE and the NGC in relation to the review of literature on prescribed medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 190913 question first answered 20/11/2018 15:07:46 answering member 4067 label Biography information for Steve Brine
	tabling member	4436 label Biography information for Cat Smith

1081710

	registered interest
	date	04/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that healthcare professionals adopt the principles set out in the 2018 NHS England guidance entitled Language Matters: Language and diabetes to enable positive interactions between people living with diabetes and physicians.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	228002
	answer	answer is ministerial correction date of answer 12/03/2019 answer text <p>‘Language Matters: Language and diabetes’ has been disseminated to all stakeholders via NHS England’s communication networks. NHS England will ensure it is used as a key reference point, where applicable, in future publications.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/03/2019 16:32:22 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon